MONDAY, Feb. 20 (HealthDay News) — Korlym (mifepristone) has been approved by the U.S. Food and Drug Administration to treat endogenous Cushing’s syndrome, a disabling disorder caused by overproduction of the so-called “stress hormone,& cortisol.
Cortisol is produced by the adrenal glands and increases blood sugar, making it particularly dangerous for people with diabetes. Korlym does [...]
Korlym Approved for Cushing’s Syndrome
20.02.2012 16:28 
0 views 
0 comments
